Aaron Kantoff

Investor

New York, New York, United States

About

Aaron Kantoff is a founder and Managing Partner of Scion, with about 15 years spent founding, building, and investing in life sciences companies focused on therapeutics. He was previously a Venture Partner at Medicxi and a Partner at Apple Tree Partners, where he helped launch several portfolio companies and worked on crossover and public biotech investments. He holds a B.S. in Finance and International Business from NYU's Stern School of Business.

LinkedIn ↗

Invests in

Biotech

Experience

Scion Life SciencesCo-Founder & Managing Partnercurrent2022 — presentNew York
Avalo TherapeuticsBoard Membercurrent2024 — presentWayne, Pennsylvania, United States
The Lustgarten FoundationBoard Membercurrent2024 — presentNew York City Metropolitan Area
Tourmaline BioBoard Member2022 — 2025New York
RayzeBioFounding Board Member2020 — 2024San Diego, California, United States
Centessa PharmaceuticalsBoard Member2020 — 2022Cambridge, Massachusetts & London, UK
medicxiVenture Partner2020 — 2021
Akero TherapeuticsBoard Member2017 — 2019San Francisco Bay Area
Corvidia TherapeuticsBoard Member2016 — 2019Greater Boston Area
Elstar Therapeutics Inc. (now Marengo Therapeutics)Board Member2015 — 2019Cambridge, MA
Apple Tree PartnersPartner2011 — 2019Greater New York City Area
Limelight Bio (now Ascidian)Board Member2016 — 2019Greater Philadelphia Area
SyntimmuneBoard Member2014 — 2018Greater Boston Area
Braeburn Pharmaceuticals, Inc.Executive Director, Business Development and Corporate Strategy2012 — 2014Princeton, New Jersey

Education

New York University - Leonard N. Stern School of BusinessB.S., Finance and International Business

Skills & more

Venture Capital32Financial Modeling27Corporate Development21Business Development13Business Strategy11Biotechnology14Entrepreneurship11Financial Analysis12Investments10Alternative Investments8Portfolio Management9Valuation11

+1 more

Pharmaceutical Industry

From Aaron's professional profile.

Shared employers

Also worked at medicxi22

Giovanni MariggiInvestor at Medicxi Richard LeeInvestor at Medicxi Giovanni PericoliniInvestor at Medicxi Victoria TaylorInvestor at Medicxi Francois PrinslooInvestor at Medicxi Freya Svedberg-KeatingInvestor at Medicxi

+ 16 more

Also worked at Akero Therapeutics4

Kevin BittermanPartner at Atlas Venture Aaron RoystonManaging Partner at venBio Partners Richard GasterManaging Partner at venBio Partners Tom HeymanExecutive Partner at Bioqube Ventures

Also worked at Apple Tree Partners7

Victor RusuPrincipal at MPM BioImpact Jernej GodecPrincipal at Atlas Venture Samuel HallManaging Partner at Scion Life Sciences Andreas LoewPartner at Scion Life Sciences Huw NashVenture Partner at Scion Life Sciences Christine BorowskiVice President at Access Biotechnology

+ 1 more

Investments

Board seats

Akero TherapeuticsAscidianAvalo TherapeuticsCentessa Pharmaceuticals PLCCorvidia TherapeuticsMarengoRayzeBioStoke TherapeuticsSyntimmuneTourmaline Bio

Per the firm's website.